Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer. by Xinzhe Dong, Xiaorong Sun, Lu Sun, Peter G Maxim, Lei Xing, Yong Huang, Wenwu Li, Honglin Wan, Xianguang Zhao, Ligang Xing, Jinming Yu

Get full text

Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume by Michael S. Binkley, Julie L. Koenig, Mehr Kashyap, Michael Xiang, Yufei Liu, Quaovi Sodji, Peter G. Maxim, Maximilian Diehn, Billy W. Loo, Michael F. Gensheimer

Get full text

FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study by Susan M. Hiniker, Susan M. Hiniker, Quaovi Sodji, Quaovi Sodji, Andrew Quon, Paulina M. Gutkin, Natasha Arksey, Edward E. Graves, Frederick T. Chin, Peter G. Maxim, Maximilian Diehn, Maximilian Diehn, Billy W. Loo, Billy W. Loo

Get full text

Increases in Serial Pretreatment 18F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy by Nicolas D. Prionas, MD, PhD, Rie von Eyben, MSc, Esther Yi, BA, Sonya Aggarwal, BA, Jenny Shaffer, MD, Jose Bazan, MD, David Eastham, MD, Peter G. Maxim, PhD, Edward E. Graves, PhD, Maximilian Diehn, MD, PhD, Michael F. Gensheimer, MD, Billy W. Loo, Jr., MD, PhD

Get full text